PIROUETTE PHARMA INC.

PORTSMOUTH, NH · Founded 2017 · CIK 0001870611 · Medtech · Private

Auto-injector platforms for injectable therapies

pirouettepharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$14M
5 Form D · Mar 2026
7 months since last filing
Contracts
—
No federal contracts on record
Patents
2
1 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,025,000
Private capital raisedForm D · SEC$6,950,000
Private capital raisedForm D · SEC$2,550,000
Private capital raisedForm D · SEC$2,350,000
Private capital raisedForm D · SEC$1,080,537
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
821Woven Orthopedic Technologies, LLC—$5.8M
822Fresenius Medical Care Linden, LLC—$1.5M
823Carestream Dental Alpha Ltd—$4.9M
824PIROUETTE PHARMA INC.—$14M
825Ictero Medical, Inc.—$2.5M
826MelioLabs Inc.—$4.0M
827Tetrous, Inc.—$2.2M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • ARUNAS CHESONISDirector · Executive Officer · Promoter
  • CONOR CULLINANEDirector · Executive Officer · Promoter
  • MATTHEW KANEDirector · Executive Officer · Promoter
  • ELIJAH KAPASDirector · Executive Officer · Promoter
  • PARINAZ MOTAMEDYDirector
  • JOSEPH NEMMERSDirector · Executive Officer · Promoter

Patents

USPTO · 1 granted of 2

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.